Recombinant Toxins: New Therapeutic Agents for Cancer
- 1 June 1995
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 758 (1), 345-354
- https://doi.org/10.1111/j.1749-6632.1995.tb24840.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- A method for increasing the yield of properly folded recombinant fusion proteins: Single-chain immunotoxins from renaturation of bacterial inclusion bodiesAnalytical Biochemistry, 1992
- The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A.Journal of Biological Chemistry, 1992
- RECOMBINANT TOXINS AS NOVEL THERAPEUTIC AGENTSAnnual Review of Biochemistry, 1992
- Recombinant Toxins as Novel Therapeutic AgentsAnnual Review of Biochemistry, 1992
- B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice.Proceedings of the National Academy of Sciences, 1991
- Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin.Proceedings of the National Academy of Sciences, 1991
- A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxinNature, 1989
- Functional domains of pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coliCell, 1987
- Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution.Proceedings of the National Academy of Sciences, 1986